OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis

R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7–33 (2021)

PubMed  Article  Google Scholar 

M.A. Thorat, R. Balasubramanian, Breast cancer prevention in high-risk women. Best Pract. Res. Clin. Obstet. Gynaecol. 65, 18–31 (2020)

PubMed  Article  Google Scholar 

L. Fan, K. Strasser-Weippl, J.-J. Li, J. St Louis, D.M. Finkelstein, K.-D. Yu, W.-Q. Chen, Z.-M. Shao, P.E. Goss, Breast cancer in China. Lancet Oncol. 15, e279–e289 (2014)

PubMed  Article  Google Scholar 

A.G. Waks, E.P. Winer, Breast cancer treatment: A review. JAMA 321, 288–300 (2019)

CAS  PubMed  Article  Google Scholar 

L. Jin, B. Han, E. Siegel, Y. Cui, A. Giuliano, X. Cui, Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biol. Ther. 19, 858–868 (2018)

CAS  PubMed  PubMed Central  Article  Google Scholar 

S. Lei, R. Zheng, S. Zhang, R. Chen, S. Wang, K. Sun, H. Zeng, W. Wei, J. He, Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. Cancer Biol. Med. (2021)

W. Zhang, J.H. Mao, W. Zhu, A.K. Jain, K. Liu, J.B. Brown, G.H. Karpen, Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy. Nat. Commun. 7, 12619 (2016)

CAS  PubMed  PubMed Central  Article  Google Scholar 

S. Rivankar, An overview of doxorubicin formulations in cancer therapy. J. Cancer Res. Ther. 10, 853–858 (2014)

PubMed  Article  Google Scholar 

Y. Bao, M. Yin, X. Hu, X. Zhuang, Y. Sun, Y. Guo, S. Tan, Z. Zhang, A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. J. Control Release. 235, 182–194 (2016)

CAS  PubMed  Article  Google Scholar 

C. Holohan, S. Van Schaeybroeck, D.B. Longley, P.G. Johnston, Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer. 13, 714–726 (2013)

CAS  PubMed  Article  Google Scholar 

H.S. Al-Malky, S.E. Al Harthi, A.M. Osman, Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance. J. Oncol. Pharm. Pract. 26, 434–444 (2020)

PubMed  Article  Google Scholar 

A. Dayton, K. Selvendiran, S. Meduru, M. Khan, M.L. Kuppusamy, S. Naidu, T. Kalai, K. Hideg, P. Kuppusamy, Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function compound, HO-3867. J. Pharmacol. Exp. Ther. 339, 350–357 (2011)

CAS  PubMed  PubMed Central  Article  Google Scholar 

S. Liu, R. Li, J. Qian, J. Sun, G. Li, J. Shen, Y. Xie, Combination therapy of Doxorubicin and Quercetin on multidrug-resistant breast cancer and their sequential delivery by reduction-sensitive hyaluronic acid-based conjugate/d-alpha-tocopheryl poly(ethylene glycol) 1000 succinate mixed micelles. Mol. Pharm. 17, 1415–1427 (2020)

CAS  PubMed  Article  Google Scholar 

T. Iguchi, M. Kuroda, R. Naito, T. Watanabe, Y. Matsuo, A. Yokosuka, Y. Mimaki, Cholestane glycosides from Ornithogalum saundersiae bulbs and the induction of apoptosis in HL-60 cells by OSW-1 through a mitochondrial-independent signaling pathway. J. Nat. Med. 73, 131–145 (2019)

CAS  PubMed  Article  Google Scholar 

Y. Zhou, C. Garcia-Prieto, D.A. Carney, R.H. Xu, H. Pelicano, Y. Kang, W. Yu, C. Lou, S. Kondo, J. Liu, D.M. Harris, Z. Estrov, M.J. Keating, Z. Jin, P. Huang, OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action. J. Natl. Cancer Inst. 97, 1781–1785 (2005)

CAS  PubMed  Article  Google Scholar 

J. Jin, X. Jin, C. Qian, Y. Ruan, H. Jiang, Signaling network of OSW1induced apoptosis and necroptosis in hepatocellular carcinoma. Mol. Med. Rep. 7, 1646–1650 (2013)

CAS  PubMed  Article  Google Scholar 

Y. Zhang, F. Fang, K. Fan, Y. Zhang, J. Zhang, H. Guo, P. Yu, J. Ma, Effective cytotoxic activity of OSW-1 on colon cancer by inducing apoptosis in vitro and in vivo. Oncol. Rep. 37, 3509–3519 (2017)

CAS  PubMed  Article  Google Scholar 

J. Maj, J.W. Morzycki, L. Rárová, J. Oklešt’ková, M. Strnad, A. Wojtkielewicz, Synthesis and biological activity of 22-deoxo-23-oxa analogues of saponin OSW-1. J. Med. Chem. 54, 3298–3305 (2011)

CAS  PubMed  Article  Google Scholar 

J. Jin, X. Jin, C. Qian, Y. Ruan, H. Jiang, Signaling network of OSW-1-induced apoptosis and necroptosis in hepatocellular carcinoma. Mol. Med. Rep. 7, 1646–1650 (2013)

CAS  PubMed  Article  Google Scholar 

J.C. Jin, X.L. Jin, X. Zhang, Y.S. Piao, S.P. Liu, Effect of OSW-1 on microRNA expression profiles of hepatoma cells and functions of novel microRNAs. Mol. Med. Rep. 7, 1831–1837 (2013)

CAS  PubMed  Article  Google Scholar 

A.W. Burgett, T.B. Poulsen, K. Wangkanont, D.R. Anderson, C. Kikuchi, K. Shimada, S. Okubo, K.C. Fortner, Y. Mimaki, M. Kuroda, J.P. Murphy, D.J. Schwalb, E.C. Petrella, I. Cornella-Taracido, M. Schirle, J.A. Tallarico, M.D. Shair, Natural products reveal cancer cell dependence on oxysterol-binding proteins. Nat. Chem. Biol. 7, 639–647 (2011)

CAS  PubMed  PubMed Central  Article  Google Scholar 

R.C. Bensen, G. Gunay, M.C. Finneran, I. Jhingan, H. Acar, A.W.G. Burgett, Small molecule targeting of oxysterol-binding protein (OSBP)-related protein 4 and OSBP inhibits ovarian cancer cell prolifesation in monolayer and spheroid cell models. ACS Pharm. Transl. Sci. 4, 744–756 (2021)

CAS  Article  Google Scholar 

X. Ding, Y. Li, J. Li, Y. Yin, OSW-1 inhibits tumor growth and metastasis by NFATc2 on triple-negative breast cancer. Cancer Med. 9, 5558–5569 (2020)

CAS  PubMed  PubMed Central  Article  Google Scholar 

C. Garcia-Prieto, K.B. Riaz Ahmed, Z. Chen, Y. Zhou, N. Hammoudi, Y. Kang, C. Lou, Y. Mei, Z. Jin, P. Huang, Effective killing of leukemia cells by the natural product OSW-1 through disruption of cellular calcium homeostasis. J. Biol. Chem. 288, 3240–3250 (2013)

CAS  PubMed  Article  Google Scholar 

M. Kimura, K. Sasaki, Y. Fukutani, H. Yoshida, I. Ohsawa, M. Yohda, K. Sakurai, Anticancer saponin OSW-1 is a novel class of selective Golgi stress inducer. Bioorg. Med. Chem. Lett. 29, 1732–1736 (2019)

CAS  PubMed  Article  Google Scholar 

Q. Sun, X. Yu, C. Peng, N. Liu, W. Chen, H. Xu, H. Wei, K. Fang, Z. Dong, C. Fu, Y. Xu, W. Lu, Activation of SREBP-1c alters lipogenesis and promotes tumor growth and metastasis in gastric cancer. Biomed. Pharmacother. 128, 110274 (2020)

CAS  PubMed  Article  Google Scholar 

Y. Xia, F. Xu, M. Xiong, H. Yang, W. Lin, Y. Xie, H. Xi, Q. Xue, T. Ye, L. Yu, Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux. Pharmacol. Res. 163, 105295 (2021)

CAS  PubMed  Article  Google Scholar 

J. Xia, Y. Inagaki, J. Gao, F. Qi, P. Song, G. Han, T. Sawakami, B. Gao, C. Luo, N. Kokudo, K. Hasegawa, Y. Sakamoto, W. Tang, Combination of cinobufacini and doxorubicin increases apoptosis of hepatocellular carcinoma cells through the Fas- and mitochondria-mediated pathways. Am. J. Chin. Med. 45, 1537–1556 (2017)

CAS  PubMed  Article  Google Scholar 

T.C. Chou, Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58, 621–681 (2006)

CAS  PubMed  Article  Google Scholar 

Y. Xia, C. Jia, Q. Xue, J. Jiang, Y. Xie, R. Wang, Z. Ran, F. Xu, Y. Zhang, T. Ye, Antipsychotic drug trifluoperazine suppresses colorectal cancer by inducing G0/G1 arrest and apoptosis. Front. Pharmacol. 10, 1029 (2019)

CAS  PubMed  PubMed Central  Article  Google Scholar 

N. Liu, Q. Sun, H. Xu, X. Yu, W. Chen, H. Wei, J. Jiang, Y. Xu, W. Lu, Hyperuricemia induces lipid disturbances mediated by LPCAT3 upregulation in the liver. FASEB J. 34, 13474–13493 (2020)

CAS  PubMed  Article  Google Scholar 

X.L. Luo, L. Lin, H. Hu, F.L. Hu, Y. Lin, M.L. Luo, L. Wang, Y.Q. He, Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice. Sci. Rep. 10, 4681 (2020)

CAS  PubMed  PubMed Central  Article  Google Scholar 

V.L. Silva, D. Ferreira, F.L. Nobrega, I.M. Martins, L.D. Kluskens, L.R. Rodrigues, Selection of novel peptides homing the 4T1 cell line: Exploring alternative targets for triple negative breast cancer. PLoS ONE 11, e0161290 (2016)

PubMed  PubMed Central  Article  Google Scholar 

K. Wang, T. Zhang, Y. Lei, X. Li, J. Jiang, J. Lan, Y. Liu, H. Chen, W. Gao, N. Xie, Q. Chen, X. Zhu, X. Liu, K. Xie, Y. Peng, E.C. Nice, M. Wu, C. Huang, Y. Wei, Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux. Autophagy 14, 269–282 (2018)

CAS  PubMed  PubMed Central  Article  Google Scholar 

Y. Shi, Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell. 9, 459–470 (2002)

CAS  PubMed  Article  Google Scholar 

A. Gross, J.M. McDonnell, S.J. Korsmeyer, BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899–1911 (1999)

CAS  Pu

留言 (0)

沒有登入
gif